| 000 | 01081 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516054522.0 | ||
| 264 | 0 | _c20120110 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1744-8328 | ||
| 024 | 7 |
_a10.1586/era.11.52 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIrshad, Sheeba | |
| 245 | 0 | 0 |
_aTherapeutic potential of PARP inhibitors for metastatic breast cancer. _h[electronic resource] |
| 260 |
_bExpert review of anticancer therapy _cAug 2011 |
||
| 300 |
_a1243-51 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPoly(ADP-ribose) Polymerase Inhibitors |
| 700 | 1 | _aAshworth, Alan | |
| 700 | 1 | _aTutt, Andrew | |
| 773 | 0 |
_tExpert review of anticancer therapy _gvol. 11 _gno. 8 _gp. 1243-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1586/era.11.52 _zAvailable from publisher's website |
| 999 |
_c21156168 _d21156168 |
||